NOS3 and cardiomyopathy: Reduced eNOS expression has been observed in cardiac tissue [28–32] and glomeruli [33–35] of diabetic animal models, and increasing NO levels has been shown to improve cardiomyopathy, reduce proteinuria, and delay renal damage [36, 37].